Maximal coronary hyperemia creates a standardized state in which the pressure relationship across a coronary narrowing can be assessed. Adenosine is typically used to induce this increased coronary blood flow during catheterization. Measuring under hyperemic conditions helps reveal whether the stenosis produces a pressure reduction consistent with impaired blood supply to the downstream heart muscle.
Angiographic imaging shows the appearance and estimated severity of a coronary narrowing, whereas Fractional Flow Reserve provides physiological information about its effect on blood flow. Comparing these perspectives helps clinicians determine whether a visible lesion is actually flow limiting. This distinction can support treatment decisions when the anatomical image alone does not establish the lesion's clinical importance.
An FFR value of 0.80 or lower generally indicates that the measured coronary narrowing is limiting blood flow enough to suggest ischemia. The value comes from the ratio of distal coronary pressure to aortic pressure during maximal hyperemia. Clinicians can use this physiological threshold to identify lesions more likely to benefit from revascularization.
The assessment takes place during cardiac catheterization. Clinicians measure pressure in the aorta and at a point beyond the coronary stenosis, then induce maximal coronary hyperemia, typically with adenosine. They calculate the distal coronary pressure-to-aortic pressure ratio and interpret the result to determine whether the narrowing produces a flow-limiting physiological effect.
Adenosine is typically administered to induce maximal coronary hyperemia before the pressure ratio is interpreted. This condition is central to the measurement because it provides the physiological setting used to evaluate the stenosis. Without considering the hyperemic state, the recorded pressure relationship would not represent the standardized assessment described for Fractional Flow Reserve.
FFR can help determine whether a coronary lesion identified during angiographic evaluation is physiologically important enough to justify percutaneous coronary intervention. Lesions showing flow-limiting values are more likely to benefit from revascularization, while lesions without that indication may not require a stent. This supports decisions based on functional significance rather than appearance alone.
By combining physiological assessment with angiographic imaging, FFR helps distinguish lesions that limit blood flow from those that are merely visible on an angiogram. This information can identify patients and lesions more likely to benefit from revascularization while reducing unnecessary stent placement. Its clinical value lies in tailoring coronary artery disease management to the measured significance of each narrowing.